Denver pharmaceutical software startup lands $7M Series B funding

After rapidly growing to more than 2,000 hospitals on its platform, Denver pharmaceutical software startup RxRevu has closed a new $7 million funding round to fuel the development of its prescription pricing platform. The Series B investment round was led by JAZZ Venture Partners, with additional investments from existing strategic health system partners. The funding allows RxRevu to focus on expanding its capabilities and explore other cost transparency services. RxRevu's electronic health record-integrated…